Publication | Closed Access

FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II Study

MedicinePathologyColorectal CancerPhase Ii StudyFirst-line TreatmentCancer TreatmentTensin Homolog ExpressionOncologyRadiation OncologyCancer Research